PHARMACOLOGICAL SPECIFICITY OF DELTA-TETRAHYDROCANNABINOL DISCRIMINATION IN RATS

被引:52
作者
BARRETT, RL [1 ]
WILEY, JL [1 ]
BALSTER, RL [1 ]
MARTIN, BR [1 ]
机构
[1] VIRGINIA COMMONWEALTH UNIV,MED COLL VIRGINIA,DEPT PHARMACOL & TOXICOL,RICHMOND,VA 23298
关键词
DELTA(9)-THC; DRUG DISCRIMINATION; BENZODIAZEPINES; SPECIFICITY;
D O I
10.1007/BF02245942
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
While many previous studies have shown that a variety of cannabinoids substitute and cross-substitute for Delta(9)-tetrahydrocannabinol (THC) in drug discrimination procedures, few have systematically examined potential THC-like effects of non-cannabinoid compounds. The purpose of the present study was to delineate further the pharmacological specificity of THC discrimination. Rats were trained to discriminate THC (3.0 mg/kg) from vehicle. Following determination of a dose-effect curve with THC, substitution tests with selected compounds from a variety of pharmacological classes, including l-phenylisopropyl adenosine, dizocilpine, dextromethorphan, clozapine, buspirone, MDL 72222, muscimol, midazolam and chlordiazepoxide, were performed. Whereas THC produced full dose-dependent substitution, substitution tests with non-cannabinoid drugs resulted in less than chance (50%) levels of responding on the THC-appropriate lever, with the exception of (+)-MDMA (2.5 mg/kg, 50%) and diazepam (3.0 mg/kg, 67%). These results are consistent with those of previous studies and suggest that the discriminative stimulus effects of THC exhibit pharmacological specificity.
引用
收藏
页码:419 / 424
页数:6
相关论文
共 22 条
[1]   DELTA-9-TETRAHYDROCANNABINOL DISCRIMINATION IN RATS AS A MODEL FOR CANNABIS INTOXICATION [J].
BALSTER, RL ;
PRESCOTT, WR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1992, 16 (01) :55-62
[2]  
BALSTER RL, 1978, DRUG DISCRIMINATION, P131
[3]   DISCRIMINATIVE STIMULUS PROPERTIES OF DELTA-9-TETRAHYDROCANNABINOL - MECHANISTIC STUDIES [J].
BROWNE, RG ;
WEISSMAN, A .
JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (8-9) :S227-S234
[4]  
COMPTON DR, 1992, J PHARMACOL EXP THER, V263, P1118
[5]  
GOLD LH, 1992, J PHARMACOL EXP THER, V262, P479
[6]   THE BENZODIAZEPINE RECEPTOR ANTAGONIST, FLUMAZENIL DOES NOT BLOCK CLINICAL EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL [J].
HOLLISTER, LE ;
GILLESPIE, HK .
LIFE SCIENCES, 1990, 47 (18) :1655-1660
[7]   DISCRIMINATIVE STIMULUS PROPERTIES OF TETRAHYDROCANNABINOLS AND RELATED DRUGS IN RATS AND PIGEONS [J].
JARBE, TUC ;
MCMILLAN, DE .
NEUROPHARMACOLOGY, 1979, 18 (12) :1023-1024
[8]  
JARBE TUC, 1988, PSYCHOPHARMACOLOGY, V94, P328
[9]  
JARBE TUC, 1987, NEUROPHARMACOLOGY, V26, P19
[10]   PERFORMANCE-BASED TESTING FOR DRUGS OF ABUSE - DOSE AND TIME PROFILES OF MARIJUANA, AMPHETAMINE, ALCOHOL, AND DIAZEPAM [J].
KELLY, TH ;
FOLTIN, RW ;
EMURIAN, CS ;
FISCHMAN, MW .
JOURNAL OF ANALYTICAL TOXICOLOGY, 1993, 17 (05) :264-272